Lindsay Frady
Nurse Practitioner · Davie, FLNPI 1821664954
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AstraZeneca at 24.2% of the total. 2025 is the largest year on record at $2,008, more than ten times the $114 reported in 2022. Among nurse practitioner clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 141 payments — averaging $29.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$489
- Amgen$481
- Lilly USA, LLC$458
- Phathom Pharmaceuticals, Inc.$353
- Bayer$223
- plus $1K from 22 others
What the payments were for
- Food & beverage$4,197100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $1,014 |
| Novo Nordisk | 14 | $489 |
| Amgen | 13 | $481 |
| Lilly USA, LLC | 30 | $458 |
| Phathom Pharmaceuticals, Inc. | 3 | $353 |
| Bayer | 11 | $223 |
| AbbVie | 7 | $149 |
| Galderma Laboratories, L.p. | 1 | $130 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Exact Sciences | 4 | $98 |
| GSK | 4 | $85 |
| CSL Behring | 3 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Novartis | 2 | $50 |
| Sanofi | 2 | $47 |
| Idorsia Pharmaceuticals US Inc | 2 | $45 |
| Pfizer | 2 | $41 |
| Shield Therapeutics Inc | 1 | $40 |
| Johnson & Johnson | 2 | $37 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Biocryst US Sales Co., LLC | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| GC Biopharma USA, Inc. | 1 | $23 |
| Vifor Pharma, Inc. | 1 | $20 |
| Ionis Pharmaceuticals, Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,197 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 18 | $161 |
| Lovastatin | 12 | $69 |
| Montelukast Sodium | 11 | $68 |
| Alprazolam | 20 | $22 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Davie
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.